论文部分内容阅读
目的探讨盐酸氨溴索雾化吸入辅助治疗支气管肺炎的临床效果。方法选择2013年1月-2014年3月医院收治的支气管肺炎患者140例,随机分为观察组和对照组各70例,对照组给予常规基础治疗,观察组在对照组基础上加用盐酸氨溴索雾化吸入治疗,比较2组临床效果。结果观察组总有效率为97.2%明显高于对照组的82.9%,差异有统计学意义(P<0.05)。观察组患者喘憋、咳嗽、肺部体征消失时间均短于对照组,差异有统计学意义(P<0.05)。观察组炎性因子改善情况较对照组明显改善,差异有统计学意义(P<0.05)。结论盐酸氨溴索雾化吸入治疗支气管肺炎,治疗作用更为直接,痰液易于排除,能够显著提高治疗效果,较快地改善患者的临床症状和体征,且无不良反应,因此盐酸氨溴索雾化吸入安全、有效,值得临床推广应用。
Objective To investigate the clinical effect of inhalation of ambroxol hydrochloride inhalation in the treatment of bronchial pneumonia. Methods Forty patients with bronchopneumonia admitted in our hospital from January 2013 to March 2014 were randomly divided into observation group and control group, 70 cases in each group. The control group was given routine basic treatment. The observation group was treated with ammonia hydrochloride Bromine inhalation therapy, the clinical effects of two groups were compared. Results The total effective rate was 97.2% in the observation group was significantly higher than 82.9% in the control group, the difference was statistically significant (P <0.05). The observation group patients with wheezing, cough, lung signs disappeared shorter than the control group, the difference was statistically significant (P <0.05). The improvement of inflammatory factors in the observation group was significantly improved compared with the control group, the difference was statistically significant (P <0.05). Conclusion Ambroxol hydrochloride inhalation treatment of bronchial pneumonia, the treatment effect is more direct, easy to rule out sputum, can significantly improve the treatment effect, to quickly improve the patient’s clinical symptoms and signs, and no adverse reactions, ambroxol hydrochloride Atomized inhalation safe and effective, worthy of clinical promotion and application.